Home » Topics » BioWorld Science

BioWorld Science
RSS

CMV protease structure reported by three different pharmaceutical companies

Sep. 27, 1996

Sankyo discloses anthelmintic agents

Sep. 27, 1996

Immunization with HIV-1 Tat protein as a strategy for AIDS vaccination

Sep. 27, 1996

New launch for dronabinol in AIDS and cancer patients

Sep. 27, 1996

Procept to develop vaginal gel for the prevention of HIV in women

Sep. 27, 1996

Sequus signs international marketing agreement for Caelyx/Doxil

Sep. 27, 1996

Remune phase II trial interim results

Sep. 27, 1996

Anti-HIV agents reported by Japanese researchers

Sep. 27, 1996

Clinical results with VIMRxyn in AIDS

Sep. 27, 1996

A novel mechanism for inhibiting HIV infection using fibronectin fragments

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...